Showing Results for: “diabetes exercise”

Public health crisis makes lack of access to healthy food, medical appointments worse for minority groups According to a national survey released by the American Diabetes Association ® (ADA) in partnership with the real-time market research platform Thrivable, those with diabetes reported financial, housing, food and medical access challenges of crisis proportions, at numbers well beyond the impact on the public at large. Fully 7.6% of respondents said they had become temporarily or permanently homeless since the start of the public health emergency–a figure 48 times higher than the national

ADA Leads 20 National Patient Advocate Groups Urging USPS Delivery Improvements The American Diabetes Association® (ADA), along with 19 other national health groups, today called on the U.S. Postal Service Postmaster General Louis DeJoy to reinstate the organization’s delivery standards as well as expressed concerns over the effect the current delays could have on 133 million Americans who suffer from chronic disease and may rely on medication deliveries to receive life-saving drugs. “While we appreciate that you have committed to halt the changes implemented earlier this summer, we believe

Survey of those living with diabetes, released by the American Diabetes Association® and dQ&A, shows unemployment for this group at a staggering 18% Alarming new data shows the disturbing trend within the diabetes population in the U.S. of high unemployment and worsening health outcomes as they are severely and disproportionately impacted by the COVID-19 pandemic. This impact has left over 34 million Americans living with diabetes even more vulnerable to poorer outcomes from the coronavirus and highlights the need for measures to help protect these Americans to be a top priority for elected

The American Diabetes Association® applauds Delaware’s governor and legislature for passing insulin co-pay cap and formulary provisions Recently, Delaware House Bill 263 was signed into law by Governor John Carney. A provision in the law limits cost sharing for insulin to $100 per 30-day supply for those with state-regulated commercial health insurance plans. The law also requires plans’ prescription drug formularies include at least one rapid, short, intermediate, and long-acting insulin on the formularies’ lowest tier. The new law, supported by the American Diabetes Association® (ADA), will

Veterans Health Administration program combining telemonitoring, self-management and medication support improves HbA1c levels within six months In a project entitled “Implementation of Intensive Telehealth Intervention for Rural Patients with Uncontrolled Diabetes,” researchers revealed improved HbA1c levels among rural patients with poorly-controlled type 2 diabetes who participated in a comprehensive telehealth program. The results were presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions®. The study found a 1.36% reduction in HBA1c levels after

The USDA’s proposed changes would result in negative implications for the lifelong health of millions and for the trajectory of diabetes in the United States The American Diabetes Association® (ADA) submitted a formal comment yesterday expressing strong opposition to a proposed rule from the U.S Department of Agriculture (USDA) seeking to weaken nutrition standards in the National School Lunch Program (NSLP) and School Breakfast Program (SBP). If the proposed rule is implemented it will not only undercut the fight against diabetes, but also fail to protect the children who rely heavily on

The 80th Scientific Sessions will be held online June 12-16, 2020 The American Diabetes Association® (ADA) is excited to announce that the 80th Scientific Sessions will be transformed into a virtual conference! The meeting will be held online on June 12-16, 2020. We have shifted the format out of an abundance of caution and in the interest of protecting our employees and participants, many of whom have one or more factors that place them in the “higher risk” category for COVID-19. ADA’s leadership has determined that a virtual experience is the best way to ensure that our entire community of

The American Diabetes Association® applauds the Utah governor and legislature for passing HB 207 Recently, Utah Governor Gary Herbert signed into law American Diabetes Association-supported legislation capping monthly copayments for insulin at $30 for a 30-day supply. House Bill 207 (HB 207) also includes an emergency refill provision that will allow people without an up-to-date prescription to get insulin immediately rather than waiting until they are able to get a refill authorized by a physician, as well as a provision directing the Utah Department of Insurance to issue a report that

For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2) inhibitor, has a renal- and cardiovascular-protective effect in reducing the progression of kidney impairment, according to the results of the CREDENCE trial presented today in a symposium at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. In the first of several renal outcomes studies of SGLT2s, the landmark Canagliflozin and Renal Events in Diabetes with Established Nephropathy

Biden Administration Recognizes Obesity Drugs as Part of Covered Obesity Treatment in Proposed Rule Today the Centers for Medicare and Medicaid Services (CMS) announced they are rethinking the way the federal and state health care programs cover obesity treatment—recognizing obesity as a chronic disease. The Administration proposes to cover Food and Drug Administration (FDA) approved medications to reduce excess weight that leads to health conditions for Medicare Part D, Medicare Advantage and Medicaid beneficiaries who have obesity. Until now, breakthrough obesity medications were only